Additionally, ACSL4 and KLF4 are key molecules in the ferroptosis signaling pathway; they can inhibit ferroptosis in breast cancer cells while maintaining their malignant biological characteristics (116, 136, 137). This evidence concerns the gene ACSL4 and breast cancer.